- Corporate Officers - R
- Rock Springs Capital Llc
Insider Trading History of Rock Springs Capital Llc
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Rock Springs Capital Llc since 2018.
This trader's CIK number is 1735397.
At the time of last reporting, Rock Springs Capital Llc was the 10% Owner of Theseus Pharmaceuticals, Inc.. (stock ticker symbol THRX).
Also see all insider trading activities at Theseus Pharmaceuticals, Inc..
Note that in the past
Rock Springs Capital LLC also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Homology Medicines, Inc. (FIXX) by Rock Springs Capital Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | FIXX | 250,000 | $4,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Theseus Pharmaceuticals, Inc. (THRX) by Rock Springs Capital Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | THRX | 250,000 | $4,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Inozyme Pharma, Inc. (INZY) by Rock Springs Capital Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | INZY | 600,000 | $9,600,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Atea Pharmaceuticals, Inc. (AVIR) by Rock Springs Capital Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | AVIR | 250,000 | $6,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Imara Inc. (IMRA) by Rock Springs Capital Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | IMRA | 250,000 | $4,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Verve Therapeutics, Inc. (VERV) by Rock Springs Capital Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | VERV | 370,000 | $7,030,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 6 companies by Rock Springs Capital Llc:
1. Homology Medicines, Inc. (FIXX)
2. Theseus Pharmaceuticals, Inc. (THRX)
3. Inozyme Pharma, Inc. (INZY)
4. Atea Pharmaceuticals, Inc. (AVIR)
5. Imara Inc. (IMRA)
6. Verve Therapeutics, Inc. (VERV)
Table 1. Insider trading of Homology Medicines, Inc. (FIXX) by Rock Springs Capital Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-04-02 | FIXX | Buy | 250,000 | 16.00 | 4,000,000 |
Table 2. Insider trading of Theseus Pharmaceuticals, Inc. (THRX) by Rock Springs Capital Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-10-12 | THRX | Buy | 250,000 | 16.00 | 4,000,000 |
Table 3. Insider trading of Inozyme Pharma, Inc. (INZY) by Rock Springs Capital Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-07-28 | INZY | Buy | 600,000 | 16.00 | 9,600,000 |
Table 4. Insider trading of Atea Pharmaceuticals, Inc. (AVIR) by Rock Springs Capital Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-11-03 | AVIR | Buy | 250,000 | 24.00 | 6,000,000 |
Table 5. Insider trading of Imara Inc. (IMRA) by Rock Springs Capital Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-03-16 | IMRA | Buy | 250,000 | 16.00 | 4,000,000 |
Table 6. Insider trading of Verve Therapeutics, Inc. (VERV) by Rock Springs Capital Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-06-21 | VERV | Buy | 370,000 | 19.00 | 7,030,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Rock Springs Capital Llc
(10% Owner of Theseus Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.